Genedrive plc (GDR) Ordinary 1.5p Shares

Sell:2.10pBuy:2.25p0.08p (3.33%)

Prices delayed by at least 15 minutes
Sell:2.10p
Buy:2.25p
Change:0.08p (3.33%)
Prices delayed by at least 15 minutes
Sell:2.10p
Buy:2.25p
Change:0.08p (3.33%)
Prices delayed by at least 15 minutes

Company Information

About this company

genedrive plc is a United Kingdom-based pharmacogenetic testing company. The Company is engaged in developing and commercializing a rapid, versatile, simple to use and robust point-of-need pharmacogenetic platform for the diagnosis of genetic variations. The Company’s products include Genedrive MT-RNR1 ID Kit, Genedrive System, and Genedrive CYP2C19 ID Kit. The Company’s flagship product Genedrive MT-RNR1 ID Kit is a single-use disposable cartridge that circumvents the requirement for cold chain logistics by providing temperature stable reagent test kits for use on their proprietary test platform. The Genedrive System is a rapid thermocycler and signal detection system, enabling PCR and isothermal based amplification techniques. It is a semi- automated system used for qualitative in vitro molecular diagnostic tests. Its Genedrive CYP2C19 ID Kit Molecular point-of-care test for rapid CYP2C19 genotyping in time-critical emergency care settings.

Key people

Gino Miele
Chief Executive Officer, Chief Scientific Officer, Executive Director
Russell Shaw
Chief Financial Officer, Executive Director, Company Secretary
Ian Gilham
Non-Executive Chairman of the Board
Tom Lindsay
Non-Executive Director
Christopher Henry Francis Yates
Non-Executive Director
Click to see more

Key facts

  • EPIC
    GDR
  • Location
    United Kingdom
  • Sector
    Technology
  • Industry
    Scientific & Technical Instr.
  • ISIN
    GB00B1VKB244
  • Market cap
    £11.81m
  • Employees
    43
  • Shares in issue
    543.14m
  • Exchange
    London Stock Exchange (LON)
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.